LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor

Related Experiment Video

Updated: Apr 3, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.9K

Min Qin1, Shihong Peng1, Ning Liu1

  • 1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China (M.Q., S.P., N.L., M.H., Y.H., G.L., H.C., Y.H., A.C., X.W., M.L., Y.C., Z.Y.); and Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology and Department of Molecular and Cellular Medicine, Texas A & M University Health Science Center, Houston, Texas (M.L.).

The Journal of Pharmacology and Experimental Therapeutics
|September 18, 2015
PubMed

Insights

A new compound, LG308, effectively targets microtubules in prostate cancer cells. It inhibits cell growth, induces cell death, and suppresses tumor growth and metastasis in preclinical models, showing promise as an anticancer drug.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Microtubules are crucial for cell division and are targeted in cancer therapy.
  • Existing microtubule-targeting drugs primarily affect microtubule mass.
  • The tubulin/microtubule system is a key therapeutic target for prostate cancer.

Purpose of the Study:

  • To investigate the effects of a novel synthetic compound, LG308, on prostate cancer cells.
  • To determine if LG308 disrupts microtubule dynamics and inhibits cancer progression.
  • To evaluate LG308 as a potential anticancer agent for prostate cancer.

Main Methods:

  • Treatment of PC-3M and LNCaP prostate cancer cell lines with LG308.
  • Analysis of microtubule polymerization, cell cycle progression (G2/M arrest), and protein expression (cyclin B1, cdc2, MPM-2).
  • Assessment of cell proliferation, colony formation, apoptosis, and in vivo tumor growth and metastasis in xenograft and orthotopic models.

Main Results:

  • LG308 inhibited microtubule polymerization and disrupted microtubule organization in prostate cancer cells.
  • LG308 induced dose-dependent G2/M phase arrest, associated with altered cyclin B1, cdc2, and MPM-2 levels.
  • LG308 suppressed cell proliferation, colony formation, induced apoptosis, and significantly inhibited tumor growth and metastasis in vivo.

Conclusions:

  • LG308 demonstrates potent antimitotic activity by inhibiting microtubule polymerization.
  • LG308 effectively suppresses prostate cancer cell growth, survival, and metastasis both in vitro and in vivo.
  • LG308 represents a promising novel therapeutic candidate for prostate cancer treatment.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.1K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.9K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
8.1K